跳至主要内容
临床试验/CTRI/2026/03/107166
CTRI/2026/03/107166尚未招募Phase 3 4

Randomized comparative clinical study to evaluate the efficacy of Phaltrikadi Ghan Vati and Tryushn Churna in the management of Medorga(Dyslipidemia)

Post Graduate Institute of Ayurved Jodhpur Rajasthan1 个研究点 分布在 1 个国家目标入组 46 人开始时间: 2026年4月15日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
46
试验地点
1

研究概览

简要总结

There will be selected 46 patients in two groups. In each group there will be 23 patients.

Study type -Interventional, Randomised Clinical Trial

Allocation -Randomization

Level of Study -OPD/IPD

Timing- Prospective

Total duration- 60 days

Purpose - I have chosen this subject and medicine because there are very limited comparative  study has been done on medoroga[Dyslipidemia] and I want to work on that.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • ) Patients age between 20-70 years of either both of sex.
  • Diagnosed cases of Dyslipidemia & Medoroga on the basis of criteria given (Serum Cholesterol greater than and equal 200 mg/dl + Total Cholesterol,HDL ratio greater than 4.5) 3) Patients having Clinical signs and symptoms due to Dyslipidaemia.

排除标准

  • ) Age below 20 years and above than 70 years 2) Patients with serious cardiovascular conditions such as unstable angina, recent myocardial infarction, uncontrolled hypertension (diastolic BP greater than 100 mmHg), or poorly managed diabetes mellitus.
  • Individuals with compromised kidney function, indicated by serum creatinine levels equal to or exceeding 2 mg/dL.
  • Patients diagnosed with or suspected of having any form of malignancy and other lifethreatening condition.
  • Pregnant or breastfeeding women, as well as individuals whose dyslipidemia is druginduced (e.g., due to glucocorticoids, diuretics, etc.).
  • Heavy drinkers and drug abusers.
  • Withdrawal Criteria: 1) During the course of trial if any serious condition or any serious adverse effect occurs.

研究者

发起方
Post Graduate Institute of Ayurved Jodhpur Rajasthan
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr shanu palaria

Post Graduate Institute Of Ayurved Dr Sarvepalli Radhakrishnan Rajasthan Ayurved university Jodhpur rajasthan

研究点 (1)

Loading locations...

相似试验